Physician profile
Obiageli Obi
NPI 1578950796
$678.89
in general payments reported to CMS, 2019-2025
18 companies · $46.95 in 2025
The $46.95 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.15 · 2021: $41.73 · 2022: $241 · 2023: $262 · 2024: $68.15 · 2025: $46.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $90.43 | 2022-2024 | Dexcom G6 Transmitter |
| Tolmar Pharmaceuticals, INC. | $83.49 | 2020-2022 | |
| Abbvie INC. | $70.80 | 2021-2023 | |
| Novo Nordisk INC | $53.95 | 2022-2023 | Norditropin |
| Amphastar Pharmaceuticals, INC. | $49.73 | 2024-2025 | |
| Biomarin Pharmaceutical INC. | $47.42 | 2022-2023 | Voxzogo 1.2mg |
| Rhythm Pharmaceuticals, INC. | $35.23 | 2023 | Imcivree |
| Xeris Pharmaceuticals, INC. | $33.72 | 2023 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $32.61 | 2022 | |
| Ascendis Pharma Endocrinology INC | $29.19 | 2023 | |
| Ibsa Pharma INC. | $22.53 | 2022 | |
| Insulet Corporation | $22.17 | 2025 | Omnipod |
| Kyowa Kirin, INC. | $21.31 | 2023 | Crysvita |
| Azurity Pharmaceuticals, INC. | $19.96 | 2023 | Gliadel |
| Medtronic, INC. | $19.96 | 2024 | Minimed 780g |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $17.04 | 2021 | |
| Pfizer INC. | $16.37 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obiageli Obi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.